Marshall Wace
KYTH

Marshall Wace’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Marshall Wace’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-32,058
Closed -$1.61M – 1155
2015
Q1 		$1.61M Buy
+32,058
New +$1.35M 0.02% 501

Other funds holding KYTH

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace's KYTH Position: Q2 2015 in Review

Marshall Wace sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 32,058 shares — an estimated $1.61M sold.

Marshall Wace first reported a position in KYTH in Q1 2015 and held it in 1 quarter. The position peaked at $1.61M in Q1 2015. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

  • Marshall Wace reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
  • Marshall Wace sold 32,058 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $1.61M.
  • Marshall Wace first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2015 and held it in 1 quarter.
  • Marshall Wace's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.61M in Q1 2015.
  • 153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on Marshall Wace's 13F filing for Q2 2015, filed 14 Aug 2015.